NEREUS Capsule Ref.[116150] Active ingredients: Tradipitant

Source: FDA, National Drug Code (US)  Revision Year: 2026 

1. Indications and Usage

NEREUS is indicated for the prevention of vomiting induced by motion in adults.

2. Dosage and Administration

2.1 Recommended Dosage and Administration

  • The recommended dosage of NEREUS is 85 mg or 170 mg as a single oral dose. Use the lowest effective dose. The safety of NEREUS for the prevention of vomiting induced by motion in adults for more than 90 doses has not been established in clinical trials [see Adverse Reactions (6.1)].
  • Administer NEREUS orally approximately 60 minutes before an event expected to cause vomiting induced by motion.
  • The maximum dosage in a 24-hour period is a single dose of 85 mg or 170 mg.
  • Administer NEREUS on an empty stomach, at least 1 hour prior to or 2 hours after a full meal [see Clinical Pharmacology (12.3)].

16.2. Storage and Handling

Store NEREUS capsules at controlled room temperature, 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].

Protect NEREUS capsules from exposure to light and moisture.

< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈